Literature DB >> 6325897

The number of ribosomes on simian virus 40 late 16S mRNA is determined in part by the nucleotide sequence of its leader.

A Barkan, J E Mertz.   

Abstract

The size distributions of polyribosomes containing each of three simian virus 40 late 16S mRNA species that differ in nucleotide sequence only within their leaders were determined. The two 16S RNA species with shorter leaders were incorporated into polysomes that were both larger (on average) and narrower in size distribution than was the predominant wild-type 16S RNA. Therefore, the nucleotide sequence of the leader can influence the number of ribosomes present on the body of an mRNA molecule. We propose a model in which the excision from leaders of sizeable translatable regions permits more frequent utilization of internally located translation initiation signals, thereby enabling genes encoded within the bodies of polygenic mRNAs to be translated at higher rates. In addition, the data provide the first direct evidence that VP1 can, indeed, be synthesized in vivo from the species of 16S mRNA that also encodes the 61-amino acid leader protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325897      PMCID: PMC368803          DOI: 10.1128/mcb.4.4.813-816.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  15 in total

Review 1.  How do eucaryotic ribosomes select initiation regions in messenger RNA?

Authors:  M Kozak
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

2.  Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40.

Authors:  P K Ghosh; V B Reddy; J Swinscoe; P Lebowitz; S M Weissman
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

3.  Characterization of poly(A+)RNA in free messenger ribonucleoprotein and polysomes of mouse Taper ascites cells.

Authors:  M D McMullen; P H Shaw; T E Martin
Journal:  J Mol Biol       Date:  1979-08-25       Impact factor: 5.469

Review 4.  Translational initiation in prokaryotes.

Authors:  L Gold; D Pribnow; T Schneider; S Shinedling; B S Singer; G Stormo
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

5.  Unspliced functional late 19S mRNAs containing intervening sequences are produced by a late leader mutant of simian virus 40.

Authors:  P K Ghosh; P Roy; A Barkan; J E Mertz; S M Weissman; P Lebowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  DNA sequence analysis of simian virus 40 mutants with deletions mapping in the leader region of the late viral mRNA's: mutants with deletions similar in size and position exhibit varied phenotypes.

Authors:  A Barkan; J E Mertz
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

7.  Identification of the SV40 agnogene product: a DNA binding protein.

Authors:  G Jay; S Nomura; C W Anderson; G Khoury
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

8.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

9.  Viable deletion mutants of simian virus 40: selective isolation by means of a restriction endonuclease from Hemophilus parainfluenzae.

Authors:  J E Mertz; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Mutants of yeast initiating translation of iso-1-cytochrome c within a region spanning 37 nucleotides.

Authors:  F Sherman; J W Stewart; A M Schweingruber
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

View more
  14 in total

1.  Simian virus 40 late transcripts lacking excisable intervening sequences are defective in both stability in the nucleus and transport to the cytoplasm.

Authors:  W S Ryu; J E Mertz
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

2.  Mechanisms of synthesis of virion proteins from the functionally bigenic late mRNAs of simian virus 40.

Authors:  S A Sedman; J E Mertz
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Both VP2 and VP3 are synthesized from each of the alternative spliced late 19S RNA species of simian virus 40.

Authors:  P J Good; R C Welch; A Barkan; M B Somasekhar; J E Mertz
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  The late spliced 19S and 16S RNAs of simian virus 40 can be synthesized from a common pool of transcripts.

Authors:  P J Good; R C Welch; W S Ryu; J E Mertz
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Translational control of human cytomegalovirus gp48 expression.

Authors:  M R Schleiss; C R Degnin; A P Geballe
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Translational efficiencies of polyomavirus late mRNA molecules that differ in the sequences of their 5' noncoding late leader exons.

Authors:  E Rhee; G G Carmichael
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Polyadenylation site selection cannot occur in vivo after excision of the 3'-terminal intron.

Authors:  X Liu; J E Mertz
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

9.  Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript.

Authors:  C R Degnin; M R Schleiss; J Cao; A P Geballe
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes.

Authors:  F Wang; L Petti; D Braun; S Seung; E Kieff
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.